Riverside Partners, LLC (“Riverside”), a Boston-based private equity firm, announces the strategic combination of Sequoia Biotech Consulting (“Sequoia”), a leading life sciences service provider helping organizations to scale rapidly and to deliver high-quality therapeutics, and Syner-G BioPharma Group (“Syner-G”), a leading provider of integrated regulatory and biopharmaceutical development services. The combined company will offer comprehensive, integrated solutions to clients across the global pharmaceutical, biotechnology, and medical device sectors. Riverside invested in Syner-G and Sequoia in October 2020 and December 2021, respectively.
Read the full article: Riverside Partners to Combine Portfolio Companies, Sequoia Biotech Consulting and Syner-G BioPharma Group, to Create Leading Pharma Services Business //
Source: https://www.prnewswire.com/news-releases/riverside-partners-to-combine-portfolio-companies-sequoia-biotech-consulting-and-syner-g-biopharma-group-to-create-leading-pharma-services-business-302251990.html